Medical research agency: 5 years of reshaping the clinical trials ecosystem in Poland
2024
Reshaping Clinical Trials in Poland
Sample size: 51000
Commentary
Evidence: high
Author Information
Author(s): Kitala Diana, Kaczmarska Katarzyna, Kornacka Joanna, Górski Krzysztof, Bylina Elżbieta, Nowak Karolina, Staszewski Rafał, Nowak-Życzyńska Zuzanna, Fendler Wojciech
Primary Institution: Medical Research Agency, Warsaw, Poland
Conclusion
The Medical Research Agency has significantly advanced clinical research in Poland over the past five years.
Supporting Evidence
- The agency signed 315 co-financing agreements worth over USD 1.03 billion.
- Clinical trials focus on cardiovascular diseases, oncology, haematology, neurology, and psychiatry.
- Training programs have been attended by 7,731 participants and 287 patients.
Takeaway
A new agency in Poland is helping to improve medical research by funding clinical trials and training researchers, which is good for patients.
Methodology
The agency funded clinical trials and established training programs for researchers.
Participant Demographics
Over 51,000 patients, including more than 13,000 with rare diseases.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website